Slick Marketing Pieces do NOT =
a status update on the products in the pipeline.
Respectfully disagree - UNTIL something concrete has been
reported as FDA APPROVED, this is still a speculative play.
And my evidence for this is where the stock trades at today....
there's a reason it's at $7+ and NOT $70 or even just double digits.
Like you, I am hoping for approvals very soon (remember Covi-Track? we've been waiting on SOMETHING since JUNE 10th FDA submission, that's now over 7 months! 7 months on a testing protocol that is severely needed in the Covid diagnosis marketplace!)
If no approvals by end of January, I will take my investment elsewhere. To date, "all talk and no results" (so to speak, that would have monetized any of their products into revenue-producing assets generating pps gains for the SHAREHOLDERS). Time running out...